Literature DB >> 2935117

Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections.

S Slopek, A Kucharewicz-Krukowska, B Weber-Dabrowska, M Dabrowski.   

Abstract

Analysis of phage therapy results was carried out on 273 cases of spontaneous and postoperative septic staphylococcal infections. The treatment appeared effective in 254 (93.0%) cases. Detailed analysis of the results obtained in particular disease categories revealed that staphylococcal bacteriophages may be efficiently applied in the treatment of suppurative staphylococcal infections resistant to antibiotics.

Entities:  

Mesh：

Year:  1985        PMID： 2935117

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN： 0004-069X            Impact factor:   4.291


  9 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

Review 3.  Phage therapy of pulmonary infections.

Authors:  Stephen T Abedon
Journal:  Bacteriophage       Date:  2015-04-18

4.  Prospects for Biocontrol of Vibrio parahaemolyticus Contamination in Blue Mussels (Mytilus edulus)-A Year-Long Study.

Authors:  Bukola A Onarinde; Ronald A Dixon
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

Review 5.  Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?

Authors:  Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2019-10-11

Review 6.  The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review.

Authors:  Alex L Clarke; Steven De Soir; Joshua D Jones
Journal:  Antibiotics (Basel)       Date:  2020-11-10

Review 7.  Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.

Authors:  Marzanna Łusiak-Szelachowska; Ryszard Międzybrodzki; Zuzanna Drulis-Kawa; Kathryn Cater; Petar Knežević; Cyprian Winogradow; Karolina Amaro; Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Justyna Rękas; Andrzej Górski
Journal:  J Biomed Sci       Date:  2022-03-30       Impact factor: 8.410

8.  A Thorough Synthesis of Phage Therapy Unit Activity in Poland-Its History, Milestones and International Recognition.

Authors:  Maciej Żaczek; Andrzej Górski; Beata Weber-Dąbrowska; Sławomir Letkiewicz; Wojciech Fortuna; Paweł Rogóż; Edyta Pasternak; Ryszard Międzybrodzki
Journal:  Viruses       Date:  2022-05-28       Impact factor: 5.818

9.  Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria.

Authors:  Masoud Sabouri Ghannad; Avid Mohammadi
Journal:  Iran J Basic Med Sci       Date:  2012-03       Impact factor: 2.699
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.